AI Summary
- Real-world evaluation of adjunctive fenfluramine in adults with Lennox-Gastaut syndrome assessing clinical effectiveness and tolerability.
- Reports on seizure-frequency outcomes, responder rates and adverse events to inform benefit-risk assessment in routine clinical care.
- Findings highlight implications for adult LGS management and the need for longer term and comparative studies to confirm effectiveness and safety.
CNS Drugs. 2026 Jun 5. doi: 10.1007/s40263-026-01307-7. Online ahead of print.
NO ABSTRACT
PMID:42247076 | DOI:10.1007/s40263-026-01307-7
AI Search
Share Evidence Blueprint

Search Google Scholar
Save as PDF

